Search Results
Preprints with The Lancet

Link to this page | View the Preprints with The Lancet landing page | Subscribe to this eJournal (requires login)

Viewing: 1 - 20 of 10,354 papers

1.

Transmission of SARS-CoV-2 Delta Variant Among Vaccinated Healthcare Workers, Vietnam

EClinicalMedicine, Volume 41, November 2021, 11043 https://doi.org/10.1016/j.eclinm.2021.101143 https://www.sciencedirect.com/science/article/pii/S2589537021004235
Nguyen Van Vinh Chau
Hospital for Tropical Diseases
Nghiem My Ngoc
Hospital for Tropical Diseases
Posted: 11 Oct 2021
Downloads 90,690
3.

Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine

Merryn Voysey
University of Oxford - Oxford Vaccine Group
Sue Ann Costa Clemens
University of Siena - Institute of Global Health
Posted: 01 Feb 2021
Downloads 51,497
4.

Safety and Immunogenicity Report from the Com-COV Study – a Single-Blind Randomised Non-Inferiority Trial Comparing Heterologous And Homologous Prime-Boost Schedules with An Adenoviral Vectored and mRNA COVID-19 Vaccine

Xinxue Liu
University of Oxford - Oxford Vaccine Group
Robert H. Shaw
University of Oxford - Oxford Vaccine Group
Posted: 25 Jun 2021
Downloads 24,154
5.

Effectiveness of First Dose of COVID-19 Vaccines Against Hospital Admissions in Scotland: National Prospective Cohort Study of 5.4 Million People

Eleftheria Vasileiou
University of Edinburgh - Asthma UK Centre for Applied Research
Colin R. Simpson
Victoria University of Wellington - School of Health
Posted: 19 Feb 2021
Downloads 20,597
6.

Effectiveness of BNT162b2 mRNA Vaccine Against Infection and COVID-19 Vaccine Coverage in Healthcare Workers in England, Multicentre Prospective Cohort Study (the SIREN Study)

Victoria Jane Hall
Public Health England Colindale
Sarah Foulkes
Public Health England Colindale
Posted: 22 Feb 2021
Downloads 17,681
7.

Revealing Global Government Health Website Accessibility Errors During COVID-19 and the Necessity of Digital Equity

Amiel A. Dror
Galilee Medical Center - Department of Otolaryngology, Head and Neck Surgery
Eli Layous
Galilee Medical Center - Department of Otolaryngology, Head and Neck Surgery
Posted: 16 Oct 2020
Downloads 13,895
8.

Young People's Voices on Climate Anxiety, Government Betrayal and Moral Injury: A Global Phenomenon

Elizabeth Marks
University of Bath
Caroline Hickman
University of Bath
Posted: 07 Sep 2021
Downloads 13,480
9.

Levels of SARS-CoV-2 Lineage P.1 Neutralization by Antibodies Elicited after Natural Infection and Vaccination

William M. de Souza
Virology Research Centre, Ribeirão Preto Medical School, University of São Paulo
Mariene R. Amorim
Laboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas
Posted: 01 Mar 2021
Downloads 12,107
10.

Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 VOC 202012/01 (B.1.1.7)

Katherine R. W. Emary
University of Oxford - Oxford Vaccine Group
Tanya Golubchik
University of Oxford - Big Data Institute
Posted: 04 Feb 2021
Downloads 9,734
11.

High Efficacy of a Low Dose Candidate Malaria Vaccine, R21 in 1 Adjuvant Matrix-M™, with Seasonal Administration to Children in Burkina Faso

Mehreen S. Datoo
University of Oxford - Centre for Clinical Vaccinology and Tropical Medicine
Hamtandi Magloire Natama
Institute de Recherche en Sciences de Santé (IRSS) - Clinical Research Unit of Nanoro
Posted: 20 Apr 2021
Downloads 8,109
12.

Tolerability and Immunogenicity After a Late Second Dose or a Third Dose of ChAdOx1 nCoV-19 (AZD1222)

Amy Flaxman
University of Oxford - The Jenner Institute
Natalie Marchevsky
University of Oxford - Oxford Vaccine Group
Posted: 28 Jun 2021
Downloads 7,835
13.

Reactogenicity and Immunogenicity of BNT162b2 in Subjects Having Received a First Dose of ChAdOx1s: Initial Results of a Randomised, Adaptive, Phase 2 Trial (CombiVacS)

Alberto M Borobia
La Paz University Hospital - Servicio de Farmacología Clínica
Antonio J Carcas
La Paz University Hospital - Servicio de Farmacología Clínica
Posted: 27 May 2021
Downloads 7,503
14.

Thromboembolic Events and Thrombosis With Thrombocytopenia After COVID-19 Infection and Vaccination in Catalonia, Spain

Edward Burn
Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
Elena Roel
Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
Posted: 20 Jul 2021
Downloads 6,878
15.

Clinical and Virological Features of SARS-CoV-2 Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta)

Sean Wei Xiang Ong
National Centre for Infectious Diseases, Singapore
Calvin J. Chiew
National Centre for Infectious Diseases, Singapore
Posted: 07 Jun 2021
Downloads 4,996
16.

Six-Month Effectiveness of BNT162B2 mRNA COVID-19 Vaccine in a Large US Integrated Health System: A Retrospective Cohort Study

Sara Y. Tartof
Southern California Kaiser Permanente Medical Group - Department of Research and Evaluation
Jeff M. Slezak
Kaiser Permanente - Southern California Kaiser Permanente Medical Group
Posted: 23 Aug 2021
Downloads 4,779
17.

Low Serum Cholesterol Level Among Patients with COVID-19 Infection in Wenzhou, China

Xingzhong Hu
Wenzhou Central Hospital
Dong Chen
Wenzhou Central Hospital
Posted: 02 Mar 2020
Downloads 4,713
18.

Effectiveness of Inactivated COVID-19 Vaccines Against COVID-19 Pneumonia and Severe Illness Caused by the B.1.617.2 (Delta) Variant: Evidence from an Outbreak in Guangdong, China

Min Kang
Guangdong Provincial Center for Disease Control and Prevention
Yao Yi
Guangdong Provincial Center for Disease Control and Prevention
Posted: 05 Aug 2021
Downloads 4,455
19.

Single Vaccination with BNT162b2 or ChAdOx1 in Older People Induces Equivalent Antibody Generation but Enhanced Cellular Responses after ChAdOx1

Helen Marie Parry
University of Birmingham - Institute of Immunology and Immunotherapy
Rachel Bruton
University of Birmingham - Institute of Immunology and Immunotherapy
Posted: 13 Apr 2021
Downloads 4,316
20.

Antiviral Effect of High-Dose Ivermectin in Adults with COVID-19: A Pilot Randomised, Controlled, Open Label, Multicentre Trial

Alejandro Krolewiecki
Universidad Nacional de Salta - Instituto de Investigaciones de Enfermedades Tropicales (IIET-CONICET)
Adrián Lifschitz
National University of Central Buenos Aires - Laboratorio de Farmacología
Posted: 11 Nov 2020
Downloads 3,995